Loading organizations...
Loading organizations...
Develops antibody therapies for neurodegenerative diseases.
Korsana Biosciences has raised $150.0M across 1 funding round.
Korsana Biosciences has raised $150.0M in total across 1 funding round.
Korsana Biosciences has raised $150.0M in total across 1 funding round.
Korsana Biosciences's investors include TCGX, Nilesh Kumar, Fairmount, Foresite Capital, Janus Henderson Investors, J.P. Morgan, Sanofi Ventures, Andrew Gottesdiener.
Korsana Biosciences has raised $150.0M across 1 funding round. Most recently, it raised $150.0M Series A in February 2026.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Feb 18, 2026 | $150.0M Series A | TCGX, Nilesh Kumar | Fairmount, Foresite Capital, Janus Henderson Investors, J.P. Morgan, Sanofi Ventures, Andrew Gottesdiener |